Okay.
What you're looking at there is a measurement mechanism that was put in place when the Patent Act was expanded back in 1987. That was done at a time when the industry was very different from the industry that exists in Canada right now.
So the first argument I would make, then, is that the measuring stick is sort of outdated and needs to be updated. Your point is still well taken, though. What is investment and what is R and D? What is happening in the industry right now?
The change in the industry is the one I alluded to earlier, which is that the large brand name companies are looking for new products and new innovations in this country. What's not captured in the PMPRB mechanism is all of my small member companies that are essentially doing their research on their own, in labs, in universities. None of that is captured as R and D in the traditional sense.
So that's not in that statistic, and that's the part that is continuing to grow. I have 130 or 140 members across the country who are all doing nothing but R and D, because that's what they're all about, and they're looking for the investment dollars.
That is what's happening, and I can say that's happening in real form. We're seeing some very significant success stories. I'll give you one particular example that is quite significant. Enobia, a company out of Montreal, developed an enzyme replacement therapy for bone disease in children. They took their drug to a point and they sold it to Alexion, which is a large multinational company, for $1.1 billion. That money is in Canada, and it will get reinvested in other start-ups.
That's the kind of ecosystem that's taking place. I think that's something we would like to keep in this country.